Sign in
4

Changes in Ownership

Jazz Pharmaceuticals plc Filed Acc 0001765581-22-000109

SVP, Head of Europe & Internat sold 531 shares at $156.98 ($83,356)

  • SVP, Head of Europe & Internat acquired 531 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pearce Samantha · SVP, Head of Europe & Internat

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-02 Exercise or conversion : show line 1 in the form +531 $109.45 $58,118 11,840 D
2022-09-02 Sale : show line 2 in the form −531 $156.98 $83,356 11,309 D
Open-market sales · 531 sh · avg $156.98 · $83,356

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-02 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) −531 9,563 D
Loading xslF345X03/edgardoc.xml…